Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics net income
Net income is the profit left for shareholders after every expense, interest and tax.
Bone Biologics's net income for the twelve months ending Sep 30, 2026 was -$2.84M. For fiscal 2025 it was -$3.11M. The highest annual figure on record is -$3.60K in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.11M | – |
| FY2024 | Dec 31, 2024 | -$4.11M | – |
| FY2023 | Dec 31, 2023 | -$8.95M | – |
| FY2022 | Dec 31, 2022 | -$1.48M | – |
| FY2021 | Dec 31, 2021 | -$1.61M | – |
| FY2020 | Dec 31, 2020 | -$1.82M | – |
| FY2019 | Dec 31, 2019 | -$3.42M | – |
| FY2018 | Dec 31, 2018 | -$4.43M | – |
| FY2017 | Dec 31, 2017 | -$7.05M | – |
| FY2016 | Dec 31, 2016 | -$25.88M | – |
| FY2015 | Dec 31, 2015 | -$13.88M | – |
| FY2014 | Dec 31, 2014 | -$4.42M | – |
| FY2012 | Oct 31, 2012 | -$5.63K | – |
| FY2011 | Oct 31, 2011 | -$4.92K | – |
| FY2010 | Oct 31, 2010 | -$3.60K | – |
| FY2009 | Oct 31, 2009 | -$10.29K | – |
| FY2008 | Oct 31, 2008 | -$13.34K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$617.65K | – |
| Q2 FY2026 | Jun 30, 2026 | -$773.70K | – |
| Q1 FY2026 | Mar 31, 2026 | -$765.99K | – |
| Q4 FY2025 | Dec 31, 2025 | -$684.64K | – |
| Q3 FY2025 | Sep 30, 2025 | -$666.74K | – |
| Q2 FY2025 | Jun 30, 2025 | -$740.52K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.02M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$941.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$783.73K | – |
| Q1 FY2024 | Mar 31, 2024 | -$865.97K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.55M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.92M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.77M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.71M | – |
| Q2 FY2022 | Jun 30, 2022 | -$469.30K | – |
| Q1 FY2022 | Mar 31, 2022 | -$689.50K | – |
| Q4 FY2021 | Dec 31, 2021 | -$177.74K | – |
| Q3 FY2021 | Sep 30, 2021 | -$509.30K | – |
| Q2 FY2021 | Jun 30, 2021 | -$491.90K | – |
| Q1 FY2021 | Mar 31, 2021 | -$431.75K | – |
| Q4 FY2020 | Dec 31, 2020 | -$453.71K | – |
| Q3 FY2020 | Sep 30, 2020 | -$394.05K | – |
| Q2 FY2020 | Jun 30, 2020 | -$380.03K | – |
| Q1 FY2020 | Mar 31, 2020 | -$596.90K | – |
| Q4 FY2019 | Dec 31, 2019 | -$531.15K | – |
| Q3 FY2019 | Sep 30, 2019 | -$561.42K | – |
| Q2 FY2019 | Jun 30, 2019 | -$925.55K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.41M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.47M | – |
| Q3 FY2018 | Sep 30, 2018 | -$241.74K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.26M | -224.3% |
| Q1 FY2018 | Mar 31, 2018 | -$1.45M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.77M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.38M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.02M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.92M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.70M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.22M | – |
See a number that looks wrong?